pharmaceutical-investing Aquinox and Astellas Announce Exclusive Licensing Agreement for Rosiptor in the Asia-Pacific Region Including Japan
pharmaceutical-investing Basilea licenses late-stage oncology drug candidate derazantinib from ArQule
pharmaceutical-investing VBL Therapeutics Presents Late Breaking Research Demonstrating Immune-cell Mediated Killing of Cancer Cells by a Novel Bi-specific Antibody at AACR
pharmaceutical-investing Moleculin Announces Patients Treated in FDA Approved Phase I/II Annamycin Clinical Trial
pharmaceutical-investing Moleculin Enters Agreement with Seidman Cancer Center to Conduct Leukemia Clinical Trials
pharmaceutical-investing Moleculin Announces Grant-Funded Collaboration to Expand Understanding of New Discovery
